Brief: Bellerophon Therapeutics Inc On October 12, 2023, Board Of Directors Approved Plan Of Liquidation And Dissolution Of Company
Oct 13 (Reuters) - Bellerophon Therapeutics Inc
BLPH.O :
* BELLEROPHON THERAPEUTICS INC: ON OCTOBER 12, 2023, BOARD
OF
DIRECTORS APPROVED PLAN OF LIQUIDATION AND DISSOLUTION OF
COMPANY
* BELLEROPHON: INTENDS TO CALL A SPECIAL MEETING OF
STOCKHOLDERS
TO SEEK APPROVAL OF PLAN OF DISSOLUTION
Source text for Eikon: ID:
Further company coverage: BLPH.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Bellerophon Therapeutics
See all newsBrief: Bellerophon Therapeutics Inc On October 12, 2023, Board Of Directors Approved Plan Of Liquidation And Dissolution Of Company
Bellerophon Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Bellerophon Therapeutics Inc expected to post a loss of 42 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Archer-Daniels-Midland, Nucor, Copper miners
U.S. STOCKS ON THE MOVE-Hubbell, Spire Global, FibroGen